DOI QR코드

DOI QR Code

Superficial and Deep Skin Preparation with Povidone-Iodine for Ventriculoperitoneal Shunt Surgery : A Technical Note

  • Craven, Claudia L. (Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery) ;
  • Thompson, Simon D. (Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery) ;
  • Toma, Ahmed K. (Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery) ;
  • Watkins, Laurence D. (Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery)
  • Received : 2017.11.08
  • Accepted : 2018.01.21
  • Published : 2019.01.01

Abstract

Objective : Ventriculoperitoneal (VP) shunt surgery is a common and effective treatment for hydrocephalus and cerebrospinal fluid disorders. Infection remains a major cause of morbidity and mortality after a VP shunt. There is evidence that a deep skin flora microbiome may have a role to play in post-operative infections. In this technical note, we present a skin preparation technique that addresses the issue of the skin flora beyond the initial incision. Methods : The patient is initially prepped, as standard, with. a single layer of 2% CHG+70% isopropyl alcohol. The novel stage is the 'double incision' whereby an initial superficial incision receives a further application of povidone-iodine prior to completing the full depth incision. Results : Of the 84 shunts inserted using the double-incision method (September 2015 to September 2016), only one developed a shunt infection. Conclusion : The double incision approach to skin preparation is a unique operative stage in VP shunt surgery that may have a role to play in reducing acute shunt infection.

Keywords

References

  1. Achermann Y, Goldstein EJ, Coenye T, Shirtliff ME : Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev 27 : 419-440, 2014 https://doi.org/10.1128/CMR.00092-13
  2. Bicknell PG : Sensorineural deafness following myringoplasty operations. J Laryngol Otol 85 : 957-961, 1971 https://doi.org/10.1017/S0022215100074272
  3. Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE : Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 136 : 1-7, 1995 https://doi.org/10.1007/BF01411427
  4. Chiou CC, Wong TT, Lin HH, Hwang B, Tang RB, Wu KG, et al. : Fungal infection of ventriculoperitoneal shunts in children. Clin Infect Dis 19 : 1049-1053, 1994 https://doi.org/10.1093/clinids/19.6.1049
  5. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. : Chlorhexidine-alcohol versus povidone-Iodine for surgical-site antisepsis. N Engl J Med 362 : 18-26, 2010 https://doi.org/10.1056/NEJMoa0810988
  6. Davis SE, Levy ML, McComb JG, Masri-Lavine L : Does age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatr Neurosurg 30 : 253-257, 1999 https://doi.org/10.1159/000028806
  7. Felbaum D, Syed HR, Snyder R, McGowan JE, Jha RT, Nair MN : Surgical adhesive drape (IO-ban) as postoperative surgical site dressing. Cureus 7 : e394, 2015
  8. George R, Leibrock L, Epstein M : Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg 51 : 804-811, 1979 https://doi.org/10.3171/jns.1979.51.6.0804
  9. Gottardi W : Iodine and iodine compounds in Block SS (ed) : Disinfection, Sterilization, and Preservation. ed 6. Philadelphia : Lea & Febiger, 1991, pp151-166
  10. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, et al. : Topographical and temporal diversity of the human skin microbiome. Science 324 : 1190-1192, 2009 https://doi.org/10.1126/science.1171700
  11. Grice EA, Segre JA : The skin microbiome. Nat Rev Microbiol 9 : 244-253, 2011 https://doi.org/10.1038/nrmicro2537
  12. Grover R, Frank ME : Regional specificity of chlorhexidine effects on taste perception. Chem Senses 33 : 311-318, 2008 https://doi.org/10.1093/chemse/bjm095
  13. Gutierrez-Murgas Y, Snowden JN : Ventricular shunt infections: immunopathogenesis and clinical management. J Neuroimmunol 276 : 1-8, 2014 https://doi.org/10.1016/j.jneuroim.2014.08.006
  14. Hemani ML, Lepor H : Skin preparation for the prevention of surgical site infection: which agent is best? Rev Urol 11 : 190-195, 2009
  15. Henschen A, Olson L : Chlorhexidine-induced degeneration of adrenergic nerves. Acta Neuropathol 63 : 18-23, 1984 https://doi.org/10.1007/BF00688466
  16. Jenkinson MD, Gamble C, Hartley JC, Hickey H, Hughes D, Blundell M, et al. : The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol. Trials 15 : 4, 2014 https://doi.org/10.1186/1745-6215-15-4
  17. Kestle JR, Riva-Cambrin J, Wellons JC 3rd, Kulkarni AV, Whitehead WE, Walker ML, et al. : A standardized protocol to reduce cerebrospinal fluid shunt infection: the hydrocephalus clinical research network quality improvement initiative. J Neurosurg Pediatr 8 : 22-29, 2011 https://doi.org/10.3171/2011.4.PEDS10551
  18. Kong HH, Segre JA : Skin microbiome: looking back to move forward. J Invest Dermatol 132(3 Pt 2) : 933-939, 2012 https://doi.org/10.1038/jid.2011.417
  19. Korinek AM, Fulla-Oller L, Boch AL, Golmard JL, Hadiji B, Puybasset L : Morbidity of ventricular cerebrospinal fluid shunt surgery in adults: an 8-year study. Neurosurgery 68 : 985-994; discussion 994-985, 2011 https://doi.org/10.1227/NEU.0b013e318208f360
  20. McClelland S 3rd, Hall WA : Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis 45 : 55-59, 2007 https://doi.org/10.1086/518580
  21. McDonnell G, Russell AD : Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12 : 147-179, 1999 https://doi.org/10.1128/CMR.12.1.147
  22. Nakatsuji T, Chiang HI, Jiang SB, Nagarajan H, Zengler K, Gallo RL : The microbiome extends to subepidermal compartments of normal skin. Nat Commun 4 : 1431, 2013 https://doi.org/10.1038/ncomms2441
  23. Pirotte BJ, Lubansu A, Bruneau M, Loqa C, Van Cutsem N, Brotchi J : Sterile surgical technique for shunt placement reduces the shunt infection rate in children: preliminary analysis of a prospective protocol in 115 consecutive procedures. Childs Nerv Syst 23 : 1251-1261, 2007 https://doi.org/10.1007/s00381-007-0415-5
  24. Ritz R, Roser F, Morgalla M, Dietz K, Tatagiba M, Will BE : Do antibioticimpregnated shunts in hydrocephalus therapy reduce the risk of infection? an observational study in 258 patients. BMC Infect Dis 7 : 38, 2007 https://doi.org/10.1186/1471-2334-7-38
  25. Simon TD, Pope CE, Browd SR, Ojemann JG, Riva-Cambrin J, Mayer-Hamblett N, et al. : Evaluation of microbial bacterial and fungal diversity in cerebrospinal fluid shunt infection. PLoS One 9 : e83229, 2014 https://doi.org/10.1371/journal.pone.0083229
  26. Theophilus SC, Adnan JS : A randomised control trial on the use of topical methicillin in reducing post-operative ventriculoperitoneal shunt infection. Malays J Med Sci 18 : 30-37, 2011
  27. Wang KW, Chang WN, Shih TY, Huang CR, Tsai NW, Chang CS, et al. : Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis 57 : 44-48, 2004
  28. Wells DL, Allen JM : Ventriculoperitoneal shunt infections in adult patients. AACN Adv Crit Care 24 : 6-12; quiz 13-14, 2013 https://doi.org/10.1097/NCI.0b013e31827be1d1
  29. Zeeuwen PL, Boekhorst J, van den Bogaard EH, de Koning HD, van de Kerkhof PM, Saulnier DM, et al. : Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol 13 : R101, 2012 https://doi.org/10.1186/gb-2012-13-11-r101